Xilio Therapeutics Inc (XLO:NASDAQ)

$0.5367 -0.00 (-0.61%)

watchlist-icon
search-icon
Profile Icon

This Week's Average Sentiment Analysis Score (0 to 100): 89

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]

Change Analysis Timeline Daily Weekly Monthly subspinner

Analysed Xilio Therapeutics Inc (XLO:NASDAQ) News Sources

Alopecia Areata Market Set to Expand by 2036, Due to the Emergence of Novel Drug Classes Such as OX40L Inhibitors, IL-2 Inhibitors, IL-7R?, and Others | DelveInsight

Le Lézard

Gilead to acquire cancer therapy developer Arcellx for up to $7.8 billion

The Economic Times

DelveInsight Business Research, LLP: Alopecia Areata Market Set to Expand by 2036, Due to the Emergence of Novel Drug Classes Such as OX40L Inhibitors, IL-2 Inhibitors, IL-7Ra ...

FinanzNachrichten.de

XLO stock
XLO stock price
XLO stock price today
XLO stock prediction
XLO earnings date
XLO news
XLO price
XLO share
XLO share price
XLO shares
XLO ceo
XLO premarket
$XLO
XLO ticker
XLO after hours
XLO stock
XLO stock price
XLO stock price today
XLO stock prediction
XLO earnings date
XLO news
XLO price
XLO share
XLO share price
XLO shares
XLO ceo
XLO premarket
$XLO
XLO ticker
XLO after hours

Xilio Therapeutics Inc (XLO:NASDAQ) FAQs

toggle

What is the current price of Xilio Therapeutics Inc (XLO:NASDAQ)?

The current price of Xilio Therapeutics Inc (XLO:NASDAQ) is $0.5367.


toggle

Xilio Therapeutics Inc (XLO:NASDAQ) absolute price change since previous trading day?

The absolute price change of Xilio Therapeutics Inc (XLO:NASDAQ) since the previous trading day is $-0.00.


toggle

Xilio Therapeutics Inc (XLO:NASDAQ) percentage price change since previous trading day?

The percentage price change of Xilio Therapeutics Inc (XLO:NASDAQ) since the previous trading day is -0.61%.


toggle

What is This Week's average sentiment score for Xilio Therapeutics Inc (XLO:NASDAQ)?

This Week's average sentiment score for Xilio Therapeutics Inc (XLO:NASDAQ) is 89 out of 100.


toggle

What is This Week's average sentiment for Xilio Therapeutics Inc (XLO:NASDAQ)?

This Week's sentiment for Xilio Therapeutics Inc (XLO:NASDAQ) is .


Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.